R. Andrew Eckert
Chairman of the Board
R. Andrew Eckert has been a director of the company since 2004 and served as the Chairman of the Board since 2014. Eckert has held several senior executive positions during his career. Between 2017 and 2019 he was the CEO of Acelity L.P., Inc., a global advanced wound care company, which was sold to 3M for $6.7 billion. Prior to Acelity, Eckert was the CEO of Valence Health, an emerging leader in value-based healthcare, which was acquired by Evolent Health in 2016. Prior to that he was CEO of TriZetto, a leader in Payer IT which was sold to Cognizant Technology Solutions Corporation in 2014 for $2.7 billion. Prior to TriZetto, Andy was Chairman and CEO of CRC Health Group, the leading behavioral health treatment provider owned by Bain Capital, which was sold to Acadia Healthcare in 2015 for $1.3 billion. Earlier in his career, Andy was CEO of Eclipsys Corporation ($500M HCIT company) from 2005-2009 and CEO of SumTotal Systems (e-learning) from 2002-2005. He started his career at ADAC Laboratories, a leader in Nuclear Medicine, PET and clinical IT where he spent 11 years, including four as Chairman and CEO until its sale to Philips Medical Systems in 2000. Eckert is also on the Board of Directors of Becton, Dickinson & Company.
Compensation and Management Development Committee
Nominating and Corporate Governance Committee